GlassScriptPhysician profile
John B Sturgeon
NPI 1942201348
$845.46
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $273 · 2020: $41.76 · 2021: $319 · 2022: $212.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $333.26 | 2019-2022 | |
| Pfizer INC. | $163.89 | 2019-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $102.67 | 2019-2021 | |
| Merck Sharp & Dohme LLC | $58.19 | 2019-2022 | |
| Celgene Corporation | $49.29 | 2021-2022 | |
| Gilead Sciences, INC. | $26.73 | 2019-2021 | |
| Janssen Scientific Affairs, LLC | $26.15 | 2019 | |
| Allergan, INC. | $19.56 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.61 | 2019 | |
| Micro-Tech Endoscopy USA, INC. | $14.05 | 2022 | |
| Ironwood Pharmaceuticals, INC | $13.02 | 2022 | |
| Janssen Biotech, INC. | $12.43 | 2022 | |
| Ferring Pharmaceuticals INC. | $11.61 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Sturgeon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.